Lysophosphatidic Acid as a Potential Biomarker for Ovarian and Other Gynecologic Cancers

Abstract

Plasma LPA levels may represent a potential biomarker for ovarian cancer and other gynecologic cancers. However, these findings are preliminary and require confirmation in larger studies.